Difficulty: Medium
Average Score: 80%
Practice
Which of the following agents is a nonselective beta receptor agonist?
Correct answer
C
Rationale
In pharmacology, understanding the mechanism of action of drugs is crucial for safe and effective prescribing. In the context of beta receptor agonists, it is important to differentiate between selective and nonselective agents.
In this question, the correct answer is C) Isoproterenol. Isoproterenol is a nonselective beta receptor agonist, meaning it stimulates both beta-1 and beta-2 adrenergic receptors. This stimulation leads to increased heart rate, contractility, and bronchodilation.
A) Norepinephrine is not a beta receptor agonist but rather an endogenous catecholamine that acts on alpha and beta receptors, leading to vasoconstriction.
B) Terbutaline is a selective beta-2 receptor agonist commonly used as a bronchodilator in conditions like asthma and COPD.
D) Dobutamine is a selective beta-1 receptor agonist used for its positive inotropic effects in conditions such as heart failure.
Understanding the selectivity of beta receptor agonists is crucial in clinical practice to select the most appropriate drug based on the desired effects and potential side effects. This knowledge is essential for healthcare professionals to make informed decisions when managing cardiovascular conditions.
In this question, the correct answer is C) Isoproterenol. Isoproterenol is a nonselective beta receptor agonist, meaning it stimulates both beta-1 and beta-2 adrenergic receptors. This stimulation leads to increased heart rate, contractility, and bronchodilation.
A) Norepinephrine is not a beta receptor agonist but rather an endogenous catecholamine that acts on alpha and beta receptors, leading to vasoconstriction.
B) Terbutaline is a selective beta-2 receptor agonist commonly used as a bronchodilator in conditions like asthma and COPD.
D) Dobutamine is a selective beta-1 receptor agonist used for its positive inotropic effects in conditions such as heart failure.
Understanding the selectivity of beta receptor agonists is crucial in clinical practice to select the most appropriate drug based on the desired effects and potential side effects. This knowledge is essential for healthcare professionals to make informed decisions when managing cardiovascular conditions.